PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	6,629	6,391	22,723	37,737	75,790
Revenue Growth (YoY)	3.72%	-71.88%	-39.79%	-50.21%	-13.67%
Cost of Revenue	6,261	5,866	12,086	16,712	21,812
Gross Profit	368.02	525.3	10,637	21,025	53,978
Selling, General & Admin	8,638	9,199	13,240	16,472	19,914
Operating Expenses	8,638	9,199	13,240	16,472	19,914
Operating Income	-8,270	-8,674	-2,603	4,553	34,064
Interest Expense	-672.71	-482.4	-663.42	-759.2	-180.42
Interest & Investment Income	253.5	0.82	2.85	24.42	233.16
Other Non Operating Income (Expenses)	121.75	881.55	-323.87	-3,222	10.95
Pretax Income	-8,568	-8,274	-3,587	596.32	34,128
Income Tax Expense	-221.9	259.95	-17.01	359.25	7,496
Net Income	-8,346	-8,534	-3,570	237.06	26,631
Net Income to Common	-8,346	-8,534	-3,570	237.06	26,631
Net Income Growth	-	-	-	-99.11%	-29.85%
Shares Outstanding (Basic)	1,563	1,563	1,563	1,373	1,250
Shares Outstanding (Diluted)	1,563	1,563	1,563	1,373	1,250
Shares Change (YoY)	-	-	13.78%	9.86%	-
EPS (Basic)	-5.34	-5.46	-2.29	0.17	21.31
EPS (Diluted)	-5.34	-5.46	-2.29	0.17	21.31
EPS Growth	-	-	-	-99.19%	-29.85%
Free Cash Flow	-2,731	1,954	-2,932	-30,995	-13,524
Free Cash Flow Per Share	-1.75	1.25	-1.88	-22.57	-10.82
Gross Margin	5.55%	8.22%	46.81%	55.71%	71.22%
Operating Margin	-124.76%	-135.72%	-11.46%	12.07%	44.95%
Profit Margin	-125.90%	-133.52%	-15.71%	0.63%	35.14%
Free Cash Flow Margin	-41.20%	30.58%	-12.90%	-82.13%	-17.84%
EBITDA	-4,321	-4,472	985.21	7,254	35,591
EBITDA Margin	-65.18%	-69.97%	4.34%	19.22%	46.96%
D&A For EBITDA	3,950	4,202	3,588	2,701	1,527
EBIT	-8,270	-8,674	-2,603	4,553	34,064
EBIT Margin	-124.76%	-135.72%	-11.46%	12.07%	44.95%
Effective Tax Rate	-	-	-	60.25%	21.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.